John R Goffin Selected Research

Nicotine Replacement Therapy

7/2020

Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John R Goffin Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 12/2002
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 05/2005
4	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 09/2013
3	Breast Neoplasms (Breast Cancer) 02/2004 - 02/2003
2	Adenocarcinoma 01/2020 - 06/2012
2	Malignant Mesothelioma 11/2016 - 11/2011
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	COVID-19 01/2020
1	Microsatellite Instability 01/2020
1	Proteinuria 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Esophagitis 03/2016
1	Neoplasm Metastasis (Metastasis) 09/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2012
1	Colonic Neoplasms (Colon Cancer) 01/2006
1	Ureteral Obstruction 04/2004
1	Heart Failure 04/2004
1	Neutropenia 04/2004
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2004
1	Endometrial Neoplasms (Endometrial Cancer) 12/2002
1	Prostatic Neoplasms (Prostate Cancer) 12/2002
1	Melanoma (Melanoma, Malignant) 12/2002

Drug/Important Bio-Agent (IBA)

3	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2006
2	PlatinumIBA 01/2019 - 03/2016
2	Pemetrexed (MTA)FDA Link 01/2019 - 03/2016
2	Pharmaceutical PreparationsIBA 03/2016 - 09/2013
2	Estrogen ReceptorsIBA 02/2004 - 10/2003
2	Keratin-5 (Keratin 5)IBA 02/2004 - 10/2003
1	Oxygen (Dioxygen)IBA 01/2021
1	Varenicline (Chantix)FDA Link 07/2020
1	SmokeIBA 07/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	regorafenibIBA 01/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Panitumumab (Vectibix)FDA Link 01/2020
1	VaccinesIBA 01/2020
1	AZD 6244IBA 01/2019
1	GSK 1363089IBA 09/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017
1	ascrinvacumabIBA 11/2016
1	Activin Receptors (Activin Receptor)IBA 11/2016
1	Cisplatin (Platino)FDA LinkGeneric 03/2016
1	Tyrosine Kinase InhibitorsIBA 09/2013
1	ErbB Receptors (EGF Receptor)IBA 09/2013
1	halichondrin BIBA 06/2012
1	Gemcitabine FDA Link 06/2012
1	eribulin FDA Link 06/2012
1	Sunitinib (Sutent)FDA Link 11/2011
1	marimastatIBA 05/2005
1	Carboplatin (JM8)FDA LinkGeneric 05/2005
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2005
1	Matrix Metalloproteinase InhibitorsIBA 05/2005
1	Cyclin EIBA 02/2004
1	Cyclin D1IBA 02/2004
1	Proteins (Proteins, Gene)FDA Link 02/2004
1	Dihydrotachysterol (AT 10)IBA 01/2004
1	guanosine 5'-monophosphorothioateIBA 12/2002

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2021 - 02/2003
3	Adjuvant Chemotherapy 01/2021 - 02/2003
3	Therapeutics 01/2020 - 11/2016
2	Radiotherapy 03/2016 - 04/2004
1	Nebulizers and Vaporizers (Inhaler) 01/2021
1	Palliative Care (Palliative Therapy) 01/2021
1	Nicotine Replacement Therapy 07/2020
1	Salvage Therapy 01/2018
1	Immunotherapy 01/2017
1	Stents 04/2004
1	Cystectomy 04/2004